首页> 外国专利> Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy

Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy

机译:表达代谢途径调节剂的载体和遗传工程免疫细胞和采用养殖细胞疗法的用途

摘要

Provided are cells, e.g., engineered immune cells, expressing recombinant or engineered molecules involved in metabolic pathways, such as those that promote or inhibit one or more metabolic steps, reactions, or pathways, for example, in T cells. Such molecules include those that induce or repress a particular functional outcome or metabolic event, for example, one that promotes differentiation or reprogramming into a particular phenotypic state, such as memory, long-lived, activated or activatable, non-exhausted, phenotype or stem-like phenotype. The cells generally further express an immune receptor, such as an antigen receptor, which may be an engineered receptor, such as a CAR or recombinant TCR, or may be a natural immune receptor. Also provided are cells, such as T cells, expressing such molecules and combinations thereof, compositions comprising such cells, nucleic acids such as vectors encoding the same, and methods of administration to subjects in adoptive cell therapy.
机译:提供的是细胞,例如工程的免疫细胞,表达参与代谢途径的重组或工程分子,例如促进或抑制一种或多种代谢步骤,例如,例如在T细胞中的那些。这些分子包括诱导或抑制特定功能结果或代谢事件的那些,例如,促进分化或重新编程为特定表型状态,例如记忆,长寿命,活化或可激活的,无耗尽,表型或茎 - 般的表型。细胞通常进一步表达免疫受体,例如抗原受体,其可以是工程受体,例如汽车或重组TCR,或者可以是天然免疫受体。还提供了细胞,例如T细胞,表达这些分子及其组合,包含这种细胞的组合物,含有这种细胞的核酸,例如编码的载体,以及给予继承细胞疗法中受试者的核酸的方法。

著录项

  • 公开/公告号US11020429B2

    专利类型

  • 公开/公告日2021-06-01

    原文格式PDF

  • 申请/专利权人 JUNO THERAPEUTICS INC.;

    申请/专利号US201615773153

  • 发明设计人 LUCAS JAMES THOMPSON;

    申请日2016-11-04

  • 分类号A61K35/17;A61K39;C12N5/0783;

  • 国家 US

  • 入库时间 2022-08-24 19:04:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号